You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The firm said that it expects to save $4 million to $5 million annually following the restructuring.
The firm will increase its focus on providing diagnostics services while aiming to trim its burn rate by 40 to 60 percent.
While most companies working in the RNAi drugs field have been able to secure the money needed to maintain operations, a number of players in the space have bowed out under unfavorable circumstances.
The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.
Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.
A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.
In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.